Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Clinical trial NCT00003993 · COMPLETED

Trial details

NCT number: NCT00003993
Sponsor: National Institute on Aging (NIA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1999-09-01
Primary completion: 2008-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.